Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

AGI-101H

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

National Cancer Institute

Drug class:

Vascular disrupting agent

Related drugs: